Product Catalog [{"id":"459","name":"Evaluation of Parsaclisib plus Ruxolitinib in patients with Myelofibrosis who have not responded to Ruxolitinib alone","price":1,"sku":"myelofibrosis-trial-1","brand":false,"position":10,"category":"Medicines\/Oncology"},{"id":"458","name":"Evaluation of Nivolumab plus Docetaxel in men with Prostate Cancer","price":1,"sku":"prostate-cancer-trial-1","brand":false,"position":11,"category":"Medicines\/Oncology"},{"id":"455","name":"Welireg","price":1,"sku":"Welireg (belzutifan)","brand":"Merck ","position":12,"category":"Medicines\/Oncology"},{"id":"447","name":"Rylaze","price":1,"sku":"Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn)","brand":"Jazz Pharmaceuticals","position":13,"category":"Medicines\/Oncology"},{"id":"445","name":"Truseltiq","price":1,"sku":"Truseltiq (infigratinib)","brand":"QED Therapeutics","position":14,"category":"Medicines\/Oncology"},{"id":"444","name":"Rybrevant","price":7507.36,"sku":"Rybrevant (amivantamab-vmjw)","brand":"Janssen Biotech","position":15,"category":"Medicines\/Oncology"},{"id":"440","name":"Inlyta","price":839.8,"sku":"Inlyta (axitinib)","brand":"Pfizer Limited","position":16,"category":"Medicines\/Oncology"},{"id":"438","name":"Jemperli","price":19355.72,"sku":"Jemperli (dostarlimab)","brand":"GlaxoSmithKline","position":17,"category":"Medicines\/Oncology"},{"id":"437","name":"Zynlonta","price":27746.55,"sku":"Zynlonta (loncastuximab tesirine-lpyl)","brand":"ADC Therapeutics","position":18,"category":"Medicines\/Oncology"}]

Oncology access options

  1. Jakavi
    Jakavi (ruxolitinib)
    Leukemia
    €2,272.99
  2. Xalkori
    Xalkori (crizotinib)
    Lung Cancer, Lymphoma
    €4,927.62
  3. Cosela
    Cosela (trilaciclib)
    Lung Cancer
    €2,581.69
  4. Reblozyl
    Reblozyl (luspatercept)
    Lymphoma
    €2,168.60
  5. Orgovyx
    Orgovyx (relugolix)
    Prostate Cancer
    €3,563.17
  6. Margenza
    Margenza (margetuximab-cmkb)
    Breast Cancer
    €2,720.25
  7. Danyelza
    Danyelza (naxitamab-gqgk)
    Neuroblastoma
    €35,282.47
  8. Padcev
    Padcev (enfortumab vedotin-ejfv)
    Urothelial Carcinoma
    €5,350.80
View as Grid List

Items 13-24 of 108

per page
Set Descending Direction
CA